Literature DB >> 6183291

Human newborns are deficient in natural killer activity.

J Kaplan, T C Shope, R O Bollinger, J Smith.   

Abstract

The peripheral blood natural killer (NK) activity of newborns was found to be significantly less than that of adults. In mixing experiments newborn cells inhibited adult NK activity in only one of nine instances. Interferon treatment in vitro increased newborn NK activity to an even greater degree than adult NK activity. These findings imply that diminished newborn NK activity is due not to inhibitory cells or lack of pre-NK cells but rather to deficient in vivo activation of pre-NK cells. This deficiency may be a major factor in the increased susceptibility of newborns to certain virus infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183291     DOI: 10.1007/bf00915078

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

1.  Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.

Authors:  C A Savary; E Lotzová
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Deficiency of immune interferon production by leukocytes of normal newborns.

Authors:  Y J Bryson; H S Winter; S E Gard; T J Fischer; E R Stiehm
Journal:  Cell Immunol       Date:  1980-09-15       Impact factor: 4.868

3.  Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells.

Authors:  S Targan; F Dorey
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

4.  Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.

Authors:  K Kuribayashi; S Gillis; D E Kern; C S Henney
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Interferon induction of natural killer cytotoxicity in human neonates.

Authors:  S Kohl; J J Frazier; S B Greenberg; L K Pickering; L S Loo
Journal:  J Pediatr       Date:  1981-03       Impact factor: 4.406

6.  Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.

Authors:  O Stutman; C J Paige; E F Figarella
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

7.  Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.

Authors:  M P Nair; S A Schwartz
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

8.  Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.

Authors:  C Ching; C Lopez
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

9.  The dual interaction of prostaglandin E2 (PGE2) and interferon (IFN) on NK lytic activation: enhanced capacity of effector-target lytic interactions (recycling) and blockage of pre-NK cell recruitment.

Authors:  S R Targan
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

Review 10.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

View more
  4 in total

Review 1.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Non-major histocompatibility complex-restricted killer cells in human cord blood: generation and cytotoxic activity in recombinant interleukin-2-supplemented cultures.

Authors:  A M Malygin; T Timonen
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

Review 3.  Neuroblastoma stage IV-S.

Authors:  T D Miale; K Kirpekar
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

4.  Interferons as cytokines regulating leukocyte functions in vivo.

Authors:  J L Virelizier
Journal:  Ann Inst Pasteur Immunol (1985)       Date:  1985 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.